Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half of fiscal year ending June 20, 2023 and full year ending June 20, 2023. For the first half, the company expects Net sales of JPY 83,000 million, Operating income of JPY 2,900 million, Net income attributable to owners of parent of JPY 1,748 million and Net income per share of JPY 115.13.

For the full year, the company expects Net sales of JPY 168,000 million, Operating income of JPY 5,800 million, Net income attributable to owners of parent of JPY 3,900 million and Net income per share of JPY 256.87.